Andreas Janzer

2.1k total citations
17 papers, 1.1k citations indexed

About

Andreas Janzer is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Andreas Janzer has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Infectious Diseases. Recurrent topics in Andreas Janzer's work include Biochemical and Molecular Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Andreas Janzer is often cited by papers focused on Biochemical and Molecular Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Andreas Janzer collaborates with scholars based in Germany, United States and Taiwan. Andreas Janzer's co-authors include Jutta Kirfel, Reinhard Buettner, Soyoung Lim, Astrid Becker, Andreas Zimmer, Roland Schüle, Kevin Struhl, Marcia C. Haigis, John M. Asara and Natalie J. German and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Andreas Janzer

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Janzer Germany	9	958	256	196	79	75	17	1.1k
Wenwen Chien United States	20	822 0.9×	212 0.8×	250 1.3×	60 0.8×	70 0.9×	29	1.1k
Yunpeng Feng China	18	935 1.0×	228 0.9×	165 0.8×	37 0.5×	82 1.1×	30	1.2k
Eftihia Cocolakis Canada	12	898 0.9×	120 0.5×	342 1.7×	73 0.9×	83 1.1×	20	1.2k
Sylvie Shen Australia	14	447 0.5×	177 0.7×	202 1.0×	85 1.1×	81 1.1×	26	840
Renduo Song United States	15	591 0.6×	273 1.1×	264 1.3×	33 0.4×	44 0.6×	29	924
Stephany Corrêa Brazil	13	432 0.5×	209 0.8×	209 1.1×	50 0.6×	35 0.5×	27	670
Stacey L. Hembruff United States	16	583 0.6×	149 0.6×	351 1.8×	59 0.7×	47 0.6×	23	890
Amy de Haar-Holleman Netherlands	8	679 0.7×	261 1.0×	188 1.0×	235 3.0×	57 0.8×	14	1.1k
Zhijie Xiao China	18	569 0.6×	125 0.5×	315 1.6×	53 0.7×	131 1.7×	37	992
Gregory Dyson United States	20	577 0.6×	326 1.3×	304 1.6×	60 0.8×	80 1.1×	74	1.1k

Countries citing papers authored by Andreas Janzer

Since Specialization

Citations

This map shows the geographic impact of Andreas Janzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Janzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Janzer more than expected).

Fields of papers citing papers by Andreas Janzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Janzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Janzer. The network helps show where Andreas Janzer may publish in the future.

Co-authorship network of co-authors of Andreas Janzer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Janzer. A scholar is included among the top collaborators of Andreas Janzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Janzer. Andreas Janzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Heller, Simon, Andreas Janzer, Helge G. Roider, et al.. (2023). Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responses. Clinical and Experimental Medicine. 23(8). 5445–5461. 7 indexed citations

Gao, Wenhua, Januka Khanal, Michael M. Levitt, et al.. (2021). Identification of De Novo Pyrimidine Synthesis as a Targetable Vulnerability in a Novel IDH1 Mutant Engineered Astrocytoma Model. International Journal of Radiation Oncology*Biology*Physics. 111(3). S86–S86. 2 indexed citations

Shi, Diana D., Michael M. Levitt, Jennifer E. Endress, et al.. (2021). DDRE-29. DE NOVO PYRIMIDINE SYNTHESIS IS A TARGETABLE VULNERABILITY IN IDH-MUTANT GLIOMA. Neuro-Oncology Advances. 3(Supplement_1). i12–i13. 1 indexed citations

Christian, Sven, Claudia Merz, Laura Evans, et al.. (2019). The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia. 33(10). 2403–2415. 146 indexed citations

Eheim, Ashley, Sven Christian, Hanna Meyer, et al.. (2019). Abstract 3597: BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of diffuse large B-cell lymphoma (DLBCL). Cancer Research. 79(13_Supplement). 3597–3597. 1 indexed citations

Ji, Zhe, Lizhi He, Asaf Rotem, et al.. (2018). Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation. Nature Communications. 9(1). 2068–2068. 18 indexed citations

Janzer, Andreas, Sabine Zitzmann-Kolbe, Sandra Berndt, et al.. (2018). Abstract LB-123: Pulsatile inhibition of PI3K converts immune suppression by Tregs and M2-TAM to anti-tumor immune response in animal models insensitive or resistant to the monotherapies of PI3K and checkpoint inhibitors. Cancer Research. 78(13_Supplement). LB–123. 4 indexed citations

Janzer, Andreas, David B. Sykes, Stefan Gradl, et al.. (2017). Abstract 3086: Inhibitors of the enzyme dihydroorotate dehydrogenase, overcome the differentiation blockade in acute myeloid leukemia. Cancer Research. 77(13_Supplement). 3086–3086. 1 indexed citations

Sievers, Elisabeth, Andreas Janzer, Dominica Willmann, et al.. (2016). Overexpression of histone demethylase Fbxl10 leads to enhanced migration in mouse embryonic fibroblasts. Experimental Cell Research. 348(2). 123–131. 5 indexed citations

10.

Sykes, David B., Youmna Kfoury, François Mercier, et al.. (2016). Inhibition of the Enzyme Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. Blood. 128(22). 1656–1656. 2 indexed citations

11.

Rotem, Asaf, Andreas Janzer, Benjamin Izar, et al.. (2015). Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Proceedings of the National Academy of Sciences. 112(18). 5708–5713. 88 indexed citations

12.

Janzer, Andreas, et al.. (2014). Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proceedings of the National Academy of Sciences. 111(29). 10574–10579. 228 indexed citations

13.

Janzer, Andreas, et al.. (2012). Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochemical and Biophysical Research Communications. 421(4). 665–670. 29 indexed citations

14.

Willmann, Dominica, Soyoung Lim, Stefan Wetzel, et al.. (2012). Impairment of prostate cancer cell growth by a selective and reversible lysine‐specific demethylase 1 inhibitor. International Journal of Cancer. 131(11). 2704–2709. 106 indexed citations

15.

Janzer, Andreas, et al.. (2012). The H3K4me3 Histone Demethylase Fbxl10 Is a Regulator of Chemokine Expression, Cellular Morphology, and the Metabolome of Fibroblasts. Journal of Biological Chemistry. 287(37). 30984–30992. 63 indexed citations

16.

Stirnberg, Marit, Angelika Horstmeyer, Stefan L. Frank, et al.. (2010). Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface. Biochemical Journal. 430(1). 87–95. 52 indexed citations

17.

Lim, Soyoung, Andreas Janzer, Astrid Becker, et al.. (2009). Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis. 31(3). 512–520. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact